These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26252799)

  • 1. Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.
    Su B; Peressin M; Ducloy C; Penichon J; Mayr LM; Laumond G; Schmidt S; Decoville T; Moog C
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1187-91. PubMed ID: 26252799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies.
    Ducloy C; Su B; Mayr L; Klingler J; Decoville T; Schmidt S; Laumond G; Salomé N; Bahram S; Moog C
    AIDS; 2018 Jun; 32(10):1239-1245. PubMed ID: 29683853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing antibodies inhibit HIV-1 transfer from primary dendritic cells to autologous CD4 T lymphocytes.
    Su B; Xu K; Lederle A; Peressin M; Biedma ME; Laumond G; Schmidt S; Decoville T; Proust A; Lambotin M; Holl V; Moog C
    Blood; 2012 Nov; 120(18):3708-17. PubMed ID: 22955927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected Cells.
    Anand SP; Ding S; Tolbert WD; Prévost J; Richard J; Gil HM; Gendron-Lepage G; Cheung WF; Wang H; Pastora R; Saxena H; Wakarchuk W; Medjahed H; Wines BD; Hogarth M; Shaw GM; Martin MA; Burton DR; Hangartner L; Evans DT; Pazgier M; Cossar D; McLean MD; Finzi A
    J Virol; 2021 Aug; 95(18):e0079621. PubMed ID: 34232070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broadly neutralizing antibody VRC01 prevents HIV-1 transmission from plasmacytoid dendritic cells to CD4 T lymphocytes.
    Su B; Lederle A; Laumond G; Ducloy C; Schmidt S; Decoville T; Moog C
    J Virol; 2014 Sep; 88(18):10975-81. PubMed ID: 24965460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection.
    Parsons MS; Le Grand R; Kent SJ
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29912167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission.
    Malbec M; Porrot F; Rua R; Horwitz J; Klein F; Halper-Stromberg A; Scheid JF; Eden C; Mouquet H; Nussenzweig MC; Schwartz O
    J Exp Med; 2013 Dec; 210(13):2813-21. PubMed ID: 24277152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of Neutralized HIV-1 by Dendritic Cells Is Dependent on the Epitope Bound by the Antibody.
    van Montfort T; Thomas AA; Krawczyk PM; Berkhout B; Sanders RW; Paxton WA
    J Immunol; 2015 Oct; 195(8):3759-68. PubMed ID: 26355155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission.
    Van Herrewege Y; Penne L; Vereecken C; Fransen K; van der Groen G; Kestens L; Balzarini J; Vanham G
    AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1091-102. PubMed ID: 12396448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.
    Gombos RB; Kolodkin-Gal D; Eslamizar L; Owuor JO; Mazzola E; Gonzalez AM; Korioth-Schmitz B; Gelman RS; Montefiori DC; Haynes BF; Schmitz JE
    J Virol; 2015 Aug; 89(15):7813-28. PubMed ID: 25995259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-Based Preventive and Therapeutic Strategies Against HIV.
    Fabra-Garcia A; Beltran C; Sanchez-Merino V; Yuste E
    Curr HIV Res; 2016; 14(3):260-9. PubMed ID: 26957200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular dendritic cells and human immunodeficiency virus infectivity.
    Heath SL; Tew JG; Tew JG; Szakal AK; Burton GF
    Nature; 1995 Oct; 377(6551):740-4. PubMed ID: 7477265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection.
    Sagar M; Akiyama H; Etemad B; Ramirez N; Freitas I; Gummuluru S
    J Infect Dis; 2012 Apr; 205(8):1248-57. PubMed ID: 22396600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of HIV-1 replication in immature dendritic cells in contact with primary CD4 T or B lymphocytes.
    Holl V; Xu K; Peressin M; Lederle A; Biedma ME; Delaporte M; Decoville T; Schmidt S; Laumond G; Aubertin AM; Moog C
    J Virol; 2010 May; 84(9):4172-82. PubMed ID: 20147388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibition of HIV-1 replication in autologous CD4
    Tu T; Zhan J; Mou D; Li W; Su B; Zhang T; Li T; Li N; Wu H; Jin C; Chen H
    Virol Sin; 2017 Dec; 32(6):485-494. PubMed ID: 28918477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralisation of HIV-1 cell-cell spread by human and llama antibodies.
    McCoy LE; Groppelli E; Blanchetot C; de Haard H; Verrips T; Rutten L; Weiss RA; Jolly C
    Retrovirology; 2014 Oct; 11():83. PubMed ID: 25700025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for competition from self during passive immunization, with application to broadly neutralizing antibodies for HIV.
    Ali Tabei SM; Li Y; Weigert M; Dinner AR
    Vaccine; 2012 Jan; 30(3):607-13. PubMed ID: 22119591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products inhibit both infection and transmission in trans of HIV-1 from monocyte-derived dendritic cells to autologous T cells.
    Nasreddine N; Borde C; Gozlan J; Bélec L; Maréchal V; Hocini H
    J Immunol; 2011 May; 186(10):5687-95. PubMed ID: 21478402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 replication in Langerhans and interstitial dendritic cells is inhibited by neutralizing and Fc-mediated inhibitory antibodies.
    Peressin M; Holl V; Schmidt S; Decoville T; Mirisky D; Lederle A; Delaporte M; Xu K; Aubertin AM; Moog C
    J Virol; 2011 Jan; 85(2):1077-85. PubMed ID: 21084491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.